| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $60.6M | +21.9% | +69.7% |
| SG&A Expense | $10.8M | -1.3% | +46.4% |
| Operating Income | -$71.4M | -17.7% | -65.7% |
| Income Tax | $115K | +21.1% | +24.9% |
| Net Income | -$69.7M | -26.3% | -97.0% |
| EPS (Basic) | -$1.10 | -26.4% | -96.4% |
| EPS (Diluted) | -$1.10 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $350.7M | +14.4% | -6.6% |
| Current Assets | $411.2M | -9.7% | -19.7% |
| Total Assets | $414.3M | -9.9% | -20.0% |
| Current Liabilities | $48.4M | +76.8% | +140.9% |
| Long-term Debt | $73.7M | +0.5% | — |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$137.2M | — | — |
| Capital Expenditures | $35K | — | — |
| Investing Cash Flow | $232.9M | — | — |
| Financing Cash Flow | $73.6M | — | — |
| Free Cash Flow | -$137.2M | — | — |
| -26.4% |
| -96.4% |
| $123.1M |
| +20.5% |
| +442.2% |
| Stockholders' Equity | $288.9M | -18.3% | -40.8% |